Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a Cohort Study using the UK Clinical Practice Research Datalink
Tesamorelin mitigates this through pulsatile release (avoiding the sustained supraphysiological GH levels that direct injection creates), and clinical trials in type 2 diabetic patients showed no significant changes in glucose control
it works best with healthy eating, movement, and sleep
N Engl J Med 375(4):311322 Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jodar E, Leiter LA et al (2016) Semaglutide and cardiovascular outcomes in patients with type 2 diabetes
Protecting Your Lean Body Mass: A Practical GLP-1 Protocol The following protocol synthesizes the evidence presented in this guide into actionable daily practices for GLP-1 users focused on muscle preservation
Booking a free consultation can help you explore your options and make an informed decision about your body and well-being